Dr Reddys Laboratories Share Price Today - Live Blog for March 26, 2025

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.15%, signalling a challenging period. Currently trading at ₹1,162.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd experienced a -0.34% slump and is currently trading at ₹1,162.45. While the stock maintains a PE ratio of 18.3400, the industry PE is 34.7548, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.54% recently. As of now, this stock is actively trading at a current market price of ₹1,171.70 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd experienced a -0.13% dip in its share price and is currently trading at ₹1,166.50. The stock has a PE ratio of 18.3400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% drop, and it's now trading at ₹1,167.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd witnessed a -0.13% decrease in its share price, and it is currently trading at ₹1,165.45. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price has fallen by -0.13%, a situation worth noting. At present, the stock is trading at ₹1,165.45. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3400, while the industry PE ratio is 34.7548.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,167.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3400, whereas the industry PE ratio stands at 34.7548.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.11%, reaching the current market price of ₹1,168.10. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd share price surged by 0.09%. With its current market price standing at ₹1,168.00 per share, this stock is garnering increased attention from the investment community.

Following a noteworthy 0.32% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,162.20. When it comes to valuation, this stock has a PE ratio of 18.3400, with the industry PE ratio at 34.7548.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.32%. At this moment, it's actively trading at ₹1,162.20, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.19%, reaching a current market price of ₹1,157.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.05% increase. Presently, it is actively trading at ₹1,160.00.

Dr Reddys Laboratories Ltd stock price decreased by -0.39%, with the current market value at ₹1,159.90 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Dr Reddys Laboratories Ltd experienced a -0.14% slump and is currently trading at ₹1,163.35. While the stock maintains a PE ratio of 18.3400, the industry PE is 34.7548, raising questions about valuation.

Following a noteworthy 0.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,165.75. When it comes to valuation, this stock has a PE ratio of 18.3400, with the industry PE ratio at 34.7548.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.07% increase and currently trading at ₹1,163.10 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a notable 0.69% surge in its share price and is presently trading at ₹1,163.00, captivating the attention of market participants.

Dr Reddys Laboratories Ltd stock price decreased by -0.16%, with the current market value at ₹1,155.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

After a -0.11% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,156.70. The stock has a PE ratio of 18.3400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a -0.20% decrease in its share price, and it is currently trading at ₹1,155.95. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a -0.60% decrease in its share price, and it is currently trading at ₹1,158.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3400, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.42% in its share price, and it currently trades at ₹1,166.05 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.31%, reaching a current market price of ₹1,170.60. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.